Sep 1, 2021 | Featured, Podcasts, Technology Updates
We’ve all been waiting for the new batch of hybrid closed-loop insulin delivery systems to be approved and released to the marketplace. The Covid-19 pandemic delayed so many trials and studies and slowed down the processes in the FDA, as folks working in...
Mar 16, 2020 | Featured, Research News, Technology Updates
Will ViaCyte’s Encaptra Cell Delivery System ‘Cure’ Type 1 Diabetes? was reported by Ginger Vieira for InsulinNation.com, 10 March 2020. ViaCyte transplants pancreatic beta-cell ‘precursors’ that mature in place as needed into islets. ViaCyte — based in San...
